Search

The preliminary results of our ongoing trial investigating CAR T cell therapy to treat patients with malignant pleural disease, including mesothelioma, show “encouraging clinical outcomes”

… Thursday, May 17, 2018 The preliminary results of our ongoing trial investigating CAR T cell therapy to treat patients with malignant pleural disease show “encouraging clinical outcomes”. Currently, 12 patients people with biopsy-proven malignant pleural disease expressing mesothelin (MSLN) are enrolled

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Friday, June 2, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: John Maciejowski Awarded the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research John Maciejowski Awarded the 2023 Pershing Square Sohn Prize for Young Investigators

Scientists at the Sloan Kettering Institute have identified a fundamentally new type of protein-sorting system in cells.

… Monday, August 12, 2019 Summary Researchers at the Sloan Kettering Institute have made a fundamental discovery about how proteins are transported to the right location inside cells.  One of the most significant scientific milestones of the 20th century was cell biologist Günter Blobel’s discovery of

Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.

… Tuesday, July 31, 2018 Summary Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face. “Keep your face always toward the sunshine — and the shadows will fall behind you,” Walt Whitman once wrote. But what the poet didn’t account

By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.

… Thursday, December 10, 2020 Summary A digital platform that relies on machine learning can accurately identify cancerous changes in breast tissue, according to a new study being presented at the 2020 San Antonio Breast Cancer Symposium. Among doctors, pathology is often considered the backbone of medicine

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.

… Tuesday, December 1, 2009 Summary Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute’s Molecular Biology Program. For Simon N. Powell, research and medicine have always been joint pursuits. Dr. Powell

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.

… Thursday, October 13, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

… Thursday, July 17, 2014 Summary A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors. Drug discovery is “a long, complex effort,” says chemical biologist Gabriela Chiosis , a member of the Sloan Kettering Institute’s Molecular Pharmacology

Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.

… Tuesday, February 21, 2017 Summary The most effective drugs being tested for head and neck cancers , which target a pathway called PI3K, have dangerous side effects. MSK researchers developed a way to use nanoparticles to deliver these drugs precisely to the tumor site, allowing lower doses to be used

Pancreatic cancer cells spread with the help of tracks laid by nerve-supporting cells called Schwann cells.

… Wednesday, August 3, 2022 Cancer relies on many tricks to survive and grow. One tactic is to manipulate cells in the noncancerous tissues and cells surrounding a tumor to help the cancer cells spread. Researchers have learned that cancer seems to have a particular fondness for nerves, traveling along